Results 141 to 150 of about 81,908 (215)

Exploring marine-derived bacterial compounds targeting the μ-opioid receptor agonists through metabolic profiling to molecular modeling. [PDF]

Sci Rep
Boudrahem D, Messaoudi O, Balit S, Kecha M, Wink J, Patel CN.   +5 more
europepmc   +1 more source

Population Studies of Polymorphisms at Loci of Neuropsychiatric Interest (Tryptophan Hydroxylase (TPH), Dopamine Transporter Protein (SLC6A3), D3 Dopamine Receptor (DRD3), Apolipoprotein E (APOE), μ Opioid Receptor (OPRM1), and Ciliary Neurotrophic Factor (CNTF))

, 1998
Joel Gelernter, Henry R. Kranzler, James Lacobelle   +2 more
openalex   +1 more source

Peripheral Antinociception Induced by Carvacrol in the Formalin Test Involves the Opioid Receptor-NO-cGMP-K⁺ Channel Pathway. [PDF]

Metabolites
Ortiz MI, Cariño-Cortés R, Fernández-Martínez E, Muñoz-Pérez VM, Castañeda-Hernández G, González-García MP.   +5 more
europepmc   +1 more source

Anti-inflammatory and renoprotective effects of difelikefalin, a kappa opioid receptor agonist, in a rat model of renal ischemia-reperfusion-induced acute kidney injury. [PDF]

BMC Nephrol
Takeuchi H, Tatemichi S, Okuhara Y.
europepmc   +1 more source

Reversal of morphine-induced respiratory depression with the µ₁-opioid receptor antagonist naloxonazine engenders excitation and instability of breathing. [PDF]

Am J Physiol Lung Cell Mol Physiol
Getsy PM, May W, Henderson F, Coffee GA, Baby SM, Hsieh YH, Lewis SJ.   +6 more
europepmc   +1 more source

Impact of Intracellular Proteins on μ-Opioid Receptor Structure and Ligand Binding. [PDF]

J Phys Chem B
Scott CE, Juechter LA, Rocha J, Jones LD, Outten B, Aishman TD, Ivers AR, Shields GC.   +7 more
europepmc   +1 more source

A µ-opioid receptor modulator that works cooperatively with naloxone. [PDF]

Nature
O'Brien ES, Rangari VA, El Daibani A, Eans SO, Hammond HR, White E, Wang H, Shiimura Y, Krishna Kumar K, Jiang Q, Appourchaux K, Huang W, Zhang C, Kennedy BJ, Mathiesen JM, Che T, McLaughlin JP, Majumdar S, Kobilka BK.   +18 more
europepmc   +1 more source

Correction: Delta opioid receptor agonists activate PI3K-mTORC1 signaling in parvalbumin-positive interneurons in mouse infralimbic prefrontal cortex to exert acute antidepressant-like effects. [PDF]

Mol Psychiatry
Yoshioka T, Yamada D, Hagiwara A, Kajino K, Iio K, Saitoh T, Nagase H, Saitoh A.   +7 more
europepmc   +1 more source

Reversal of Diabetic Dry Eye by Topical Opioid Receptor Blockade Follows Dual Pathways. [PDF]

Invest Ophthalmol Vis Sci
Diaz D, Sassani JW, Zagon IS, McLaughlin PJ.   +3 more
europepmc   +1 more source

Mu Opioid Receptor Positive Allosteric Modulator BMS-986122 Confers Agonist-Dependent G Protein Subtype Signaling Bias. [PDF]

Biochemistry
Grieble GM, Knapp BI, Bidlack JM.
europepmc   +1 more source